Orexigenic Action of Peripheral Ghrelin Is Mediated by Neuropeptide Y and Agouti-Related Protein
Merck & Co., Inc., Rahway, NJ, USA (United States) · Baylor College of Medicine
Abstract
Ghrelin, a stomach-derived orexigenic hormone, has stimulated great interest as a potential target for obesity control. Pharmacological evidence indicates that ghrelin's effects on food intake are mediated by neuropeptide Y (NPY) and agouti-related protein (AgRP) in the central nervous system. These include intracerebroventricular application of antibodies to neutralize NPY and AgRP, and the application of an NPY Y1 receptor antagonist, which blocks some of the orexigenic effects of ghrelin. Here we describe treatment of Agrp(-/-);Npy(-/-) and Mc3r(-/-);Mc4r(-/-) double knockout mice as well as Npy(-/-) and Agrp(-/-) single knockout mice with either ghrelin or an orally active nonpeptide ghrelin agonist. The…
Citation impact
- FWCI
- 15.46
- Percentile
- 100%
- References
- 35
Authors
17- HYH. Y. ChenCorresponding
Merck & Co., Inc., Rahway, NJ, USA (United States)
- MEMyrna E. Trumbauer
Merck & Co., Inc., Rahway, NJ, USA (United States)
- ASA. S. Chen
Merck & Co., Inc., Rahway, NJ, USA (United States)
- DTDrew T. Weingarth
Merck & Co., Inc., Rahway, NJ, USA (United States)
- JRJ. R. Adams
Merck & Co., Inc., Rahway, NJ, USA (United States)
Topics & keywords
- Orexigenic
- Internal medicine
- Endocrinology
- Neuropeptide Y receptor
- Ghrelin
- Peripheral
- Neuropeptide
- Medicine
- Zero hunger